Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Kogut (Warszawa, Poland). Opioid-neurotensin hybrid influences pulmonary inflammatory process in murine model of non-atopic asthma.. 1047

Member's Comments

No comment yet.

Related content which might interest you: The impact of obesity on airway and lung parenchyma remodelling in a murine model of chronic allergic asthma Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008 Gender effect on airway and lung parenchyma remodelling in an experimental model of chronic allergic asthma Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008 Effects of OVA-induced allergic airway inflammation and remodeling in mice in three distinct asthma models Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 IL-13-dependent C3a-release in a murine model of allergic asthma Source: Annual Congress 2005 - Airway epithelial cells in asthma and COPD Year: 2005 ST2 gene knockout attenuates allergic airways disease Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs Year: 2006 Models of asthma employing ovalbumin in rats and mice: similarities and differences compared with patient asthma Source: Annual Congress 2005 - PG11 - Experimental models for COPD and asthma Year: 2005 Obesity enhances allergen-induced airway inflammation in a murine model of asthma Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Identifying eosinophil subsets in a mouse model of pollutant-aggravated allergic asthma Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021 Development of a mouse model of airway inflammation and remodeling in experimental asthma Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 Murine models of asthma Source: Eur Respir J 2003; 22: 374-382 Year: 2003 A 4-week model of allergic airways inflammation that exhibits the 3 salient features of asthma. Source: International Congress 2017 – Animal models of asthma and allergies Year: 2017 Alamandine reduces eosinophilic inflammation in an experimental model of asthma Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD Year: 2018 A role of fungal extracts on allergic airway inflammation in the ovalbumin-induced asthma model Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Photobiomodulation and corticosteroid modulate pulmonary inflammation and airway reactivity in an experimental model of chronic asthma Source: International Congress 2018 – Basic pharmacology Year: 2018 Characterisation of type two immune responses in a murine model of allergic airway disease Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020 Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007 Mast cell myositis is associated with airway remodelling in a chronic model of murine asthma Source: Eur Respir J 2006; 28: Suppl. 50, 226s Year: 2006 Effect of previous physical conditioning on pulmonary inflammation and allergic immune response in a chronic allergic airway inflammation in mice Source: Eur Respir J 2007; 30: Suppl. 51, 370s Year: 2007 Comparison of the inflammatory response between two chronic models of allergic lung inflammation Source: Eur Respir J 2007; 30: Suppl. 51, 368s Year: 2007